IP Library › Assignment 010572/0042
Patent Assignment
Reel/Frame 010572/0042

Security Agreement

Recorded: 2000-02-08 Pages: 14
Assignor
SHIRE LABORATORIES INC.
Executed: 1999-12-23
Assignee
DLJ CAPITAL FUNDING, INC. AS ADMINISTRATIVE AGENT
277 PARK AVENUE, NEW YORK, NEW YORK, 10172
Covered Properties (14)
Production of Butyrylcholinesterase
Patent: 5,272,080 →
Application: 07/657,089 →
Advanced Drug Delivery System and Method of Treating Psychiatric, Neurological and Other Disorders with Carbamazepine
Patent: 5,326,570 →
Application: 07/734,541 →
Hydrophobic Drug Delivery Systems
Patent: 5,430,021 →
Application: 08/210,014 →
Sustained-Release Drug Delivery System
Patent: 5,484,608 →
Application: 08/218,757 →
Multilamellar Drug Delivery Systems
Patent: 5,447,729 →
Application: 08/224,340 →
Emulsified Drug Delivery Systems
Patent: 5,952,004 →
Application: 08/424,521 →
Advanced Drug Delivery System and Method of Treating Psychiatric, Neurological and Other Disorders with Carbamazepine
Patent: 5,912,013 →
Application: 08/426,394 →
Oral Insulin Delivery
Patent: 5,824,638 →
Application: 08/446,399 →
Oral Acyclovir Delivery
Patent: 5,883,103 →
Application: 08/475,036 →
Emulsified Drug Delivery System
Patent: 5,897,876 →
Application: 08/879,994 →
Soluble Form Osmotic Dose Delivery System
Patent: 6,110,498 →
Application: 08/954,947 →
Oral Induction of Tolerance to Parenterally Administered Non-Autologous Polypeptides
Patent: 5,948,407 →
Application: 09/045,886 →
Oral Pulsed Dose Drug Delivery System
Patent: 6,322,819 →
Application: 09/176,542 →
Publication: US 2001/0055613
Single Phase Solid Solution Beadlet
Application: 60/059,408 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 27, 1997
From: RUDNIC, EDWARD; MCCARTY, JOHN; BURNSIDE, BETH; MCGUINNESS, CHARLOTTE
To: PHARMAVENE, INC.
Reel/Frame 008326/0408 →
Assignment of Assignor's Interest Feb 7, 1997
From: RUDNIC, EDWARD M., EXECUTRIX OF GEORGE BELENDUIK, DECEASED; BELENDUIK, KRYSTYNA, EXECUTRIX OF GEORGE BELENDUIK, DECEASED
To: PHARMAVENE, INC.
Reel/Frame 008254/0505 →
Assignment of Assignor's Interest Feb 25, 1997
From: BURNSIDE, BETH A.; MATTES, CAROL E.; MCGUINNESS, CHARLOTTE; RUDNIC, EDWARD M.
To: PHARMAVENE, INC.
Reel/Frame 008368/0471 →
Assignment of Assignor's Interest Mar 3, 1997
From: RUDNIC, EDWARD M.; BELENDIUK, KRYSTYNA, AS EXECUTRIX FOR THE ESTATE OF GEORGE W. BELENDIUK, DECEASED
To: PHARMAVENE, INC.
Reel/Frame 008406/0094 →
Assignment of Assignor's Interest Oct 22, 1997
From: RUDNIC, EDWARD M.; BURNSIDE, BETH A.; FLANNER, HENRY H.; WASSINK, SANDRA E.
To: SHIRE LABORATORIES, INC.
Reel/Frame 008866/0490 →
Change of Name and Merger Dec 8, 1997
From: PHARMAVENE, INC.
To: SHIRE LABORATORIES, INC.
Reel/Frame 008842/0708 →
Merger Dec 8, 1997
From: PHARMAVENE, INC.
To: SHIRE LABORATORIES, INC.
Reel/Frame 008842/0231 →
Merger and Change of Name Dec 8, 1997
From: PHARMAVENE, INC.
To: SHIRE LABORATORIES, INC.
Reel/Frame 008842/0228 →
Merger and Change of Name Dec 8, 1997
From: PHARMAVENE, INC.
To: SHIRE LABORATORIES, INC.
Reel/Frame 008841/0812 →
Merger/Change of Name Dec 8, 1997
From: PHARMAVENE, INC.
To: SHIRE LABORATORIES, INC.
Reel/Frame 008841/0661 →
Merger and Change of Name Dec 8, 1997
From: PHARMAVENE, INC.
To: SHIRE LABORATORIES, INC.
Reel/Frame 008841/0819 →
Merger & Change of Name Dec 8, 1997
From: PHARMAVENE, INC.
To: SHIRE LABORATORIES, INC.
Reel/Frame 008845/0058 →
Merger and Change of Name Dec 8, 1997
From: PHARMAVENE, INC.
To: SHIRE LABORATORIES, INC.
Reel/Frame 008845/0052 →
Merger Feb 17, 1998
From: PHARMAVENE, INC.
To: SHIRE LABORATORIES, INC.
Reel/Frame 009020/0060 →
Assignment of Assignor's Interest Sep 23, 1999
From: PINKETT, JILL E.
To: SHIRE LABORATORIES, INC.
Reel/Frame 010267/0937 →
Release of Security Interest Under the Amended and Restated Credit Agreement Dec 19, 2005
From: DLJ CAPITAL FUNDING, INC. AS ADMINISTRATIVE AGENT
To: SHIRE LABORATORIES, INC.
Reel/Frame 016914/0056 →
Assignment of Assignor's Interest May 10, 2006
From: SHIRE LABORATORIES, INC
To: SUPERNUS PHARMACEUTICALS, INC
Reel/Frame 017596/0304 →
Merger Dec 19, 2006
From: SHIRE LABORATORIES, INC.
To: SHIRE LLC
Reel/Frame 018654/0073 →
Merger Feb 23, 2007
From: SHIRE LABORATORIES, INC.
To: SHIRE LLC
Reel/Frame 019147/0302 →
License Oct 30, 2009
From: SHIRE LABORATORIES INC.
To: ENDO PHARMACEUTICALS SOLUTIONS INC. FORMERLY INDEVUS PHARMACEUTICALS, INC.
Reel/Frame 023449/0563 →
Corrective Assignment to Correct the Incorrect Patent Number 6890970 Previously Recorded on Reel 023449 Frame 0563. Assignor(S) Hereby Confirms the License. Dec 14, 2009
From: SHIRE LABORATORIES INC.
To: ENDO PHARMACEUTICALS SOLUTIONS INC. FORMERLY INDEVUS PHARMACEUTICALS INC.
Reel/Frame 023639/0961 →
Confirmatory Grant of Security Interest in United States Patents (Exclusively Licensed Patents) Feb 13, 2010
From: ENDO PHARMACEUTICALS INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 023928/0628 →
Release of Security Interest Recorded at Reel/Frame 23928/628 Dec 9, 2010
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ENDO PHARMACEUTICALS INC.
Reel/Frame 025456/0778 →
Confirmatory Grant of Security Interest in United States Patents (Exclusively Licensed Patents) Dec 9, 2010
From: ENDO PHARMACEUTICALS INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 025456/0172 →
Security Interest in Exclusively Licensed Patents Jul 8, 2011
From: ENDO PHARMACEUTICALS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 026561/0978 →